JOSHUA LEE: Open Payments
NPI 1114132701 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 23 payments from 7 companies in 2025. Trend: 2023 $277 · 2024 $354 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 8 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $116 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Invivyd Inc | 1 | $30 |
| Medline Industries LP | 1 | $24 |
| Janssen Biotech, Inc. | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: UPTRAVI, OFEV, JASCAYD, NUCALA, PEMGARDA, TREMFYA, GLASSIA.
Industry payments across NY — which companies pay providers there.
